CMPX
Compass Therapeutics, Inc.
+0.08 (+4.37%)1.91USD1.1M成交股數344M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-05下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 76K · 0.00 |
| 近 180 天 淨額 | 76K |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-29 | 04-30 | Anderman Jonathan | General Counsel | P 公開市場買進 | 25.0K | 1.89 | 47K | 196K | SEC |
| 2026-04-29 | 04-30 | Lerner Neil | Chief Accounting Officer | P 公開市場買進 | 15.0K | 1.89 | 28K | 398K | SEC |
| 2026-04-29 | 04-29 | Lerner Neil | Chief Accounting Officer | A 獲配股票 | 15.0K | 1.89 | 28K | 398K | SEC |
| 2026-04-29 | 04-29 | Anderman Jonathan | General Counsel | A 獲配股票 | 25.0K | 1.89 | 47K | 196K | SEC |
| 2026-02-08 | 02-10 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | F 繳稅扣股 | 36.7K | 6.52 | 239K | 6.6M | SEC |
| 2026-01-09 | 01-12 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | F 繳稅扣股 | 46.8K | 5.35 | 250K | 6.6M | SEC |
| 2026-01-02 | 01-05 | Anderman Jonathan | General Counsel | A 獲配股票 | 150K | 5.17 | 776K | 171K | SEC |
| 2026-01-02 | 01-05 | Lerner Neil | Chief Accounting Officer | A 獲配股票 | 62.5K | 5.17 | 323K | 383K | SEC |
| 2026-01-02 | 01-05 | Schuetz Thomas J. | CEO | A 獲配股票 | 250K | 5.17 | 1.3M | 6.7M | SEC |
| 2026-01-02 | 01-05 | Shin Barry | CFO | A 獲配股票 | 125K | 5.17 | 646K | 525K | SEC |
| 2025-11-16 | 11-18 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | F 繳稅扣股 | 44.0K | 4.83 | 213K | 6.4M | SEC |
| 2025-05-27 | 05-27 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | P 公開市場買進 | 10.0K | 2.11 | 21K | 6.5M | SEC |
| 2025-04-09 | 04-11 | ORBIMED ADVISORS LLC | Director,TenPercentOwner | S 公開市場賣出 | 3.6M | 1.59 | 5.7M | 0 | SEC |
| 2025-04-09 | 04-11 | OrbiMed Capital GP VI LLC | Director,TenPercentOwner | S 公開市場賣出 | 3.6M | 1.59 | 5.7M | 0 | SEC |
| 2025-04-09 | 04-11 | OrbiMed Genesis GP LLC | Director,TenPercentOwner | S 公開市場賣出 | 3.6M | 1.59 | 5.7M | 0 | SEC |
| 2025-04-09 | 04-11 | GORDON CARL L | Director,TenPercentOwner | S 公開市場賣出 | 3.6M | 1.59 | 5.7M | 0 | SEC |
| 2025-04-07 | 04-08 | Lerner Neil | CHIEF ACCOUNTING OFFICER | P 公開市場買進 | 20.0K | 1.42 | 28K | 320K | SEC |
| 2025-04-07 | 04-08 | Anderman Jonathan | Gen Counsel & Corporate Sec | P 公開市場買進 | 20.0K | 1.54 | 31K | 21.0K | SEC |
| 2025-02-08 | 02-11 | Schuetz Thomas J. | CEO | F 繳稅扣股 | 41.7K | 3.50 | 146K | 6.5M | SEC |
| 2025-01-09 | 01-13 | Schuetz Thomas J. | CEO | F 繳稅扣股 | 58.1K | 1.86 | 108K | 6.5M | SEC |
| 2024-12-09 | 12-10 | Shin Barry | CFO | A 獲配股票 | 400K | 1.65 | 660K | 400K | SEC |
| 2024-02-08 | 02-09 | Schuetz Thomas J. | PRESIDENT | F 繳稅扣股 | 44.8K | 1.45 | 65K | 6.6M | SEC |
| 2024-02-08 | 02-09 | Bisker-Leib Vered | CHIEF EXECUTIVE OFFICER | F 繳稅扣股 | 49.2K | 1.45 | 71K | 3.1M | SEC |
| 2024-01-09 | 01-10 | Schuetz Thomas J. | President of R&D | A 獲配股票 | 638K | 1.93 | 1.2M | 6.6M | SEC |
| 2024-01-09 | 01-10 | Bisker-Leib Vered | Chief Executive Officer | A 獲配股票 | 1.8M | 1.93 | 3.4M | 3.2M | SEC |
| 2023-11-17 | 11-21 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | F 繳稅扣股 | 44.0K | 1.50 | 66K | 6.0M | SEC |
| 2023-11-17 | 11-21 | Bisker-Leib Vered | Chief Operating Officer | F 繳稅扣股 | 64.4K | 1.50 | 97K | 1.4M | SEC |
| 2023-03-10 | 03-10 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | P 公開市場買進 | 10.0K | 3.37 | 34K | 6.0M | SEC |
| 2023-02-27 | 02-27 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | P 公開市場買進 | 20.0K | 3.98 | 80K | 6.0M | SEC |
| 2023-02-15 | 02-15 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | P 公開市場買進 | 20.0K | 3.86 | 77K | 6.0M | SEC |
| 2023-02-08 | 02-09 | Bisker-Leib Vered | Chief Operating Officer | A 獲配股票 | 400K | – | – | 1.5M | SEC |
| 2023-02-08 | 02-09 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | A 獲配股票 | 500K | – | – | 6.0M | SEC |
| 2023-01-31 | 01-31 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | P 公開市場買進 | 20.0K | 4.05 | 81K | 5.5M | SEC |
| 2023-01-24 | 01-24 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | P 公開市場買進 | 20.0K | 4.19 | 84K | 5.5M | SEC |
| 2022-11-25 | 11-25 | Bisker-Leib Vered | Chief Operating Officer | S 公開市場賣出 | 2 | 4.36 | 8.72 | 1.1M | SEC |
| 2022-11-23 | 11-25 | Bisker-Leib Vered | Chief Operating Officer | S 公開市場賣出 | 9.6K | 4.30 | 41K | 1.1M | SEC |
| 2022-11-22 | 11-25 | Bisker-Leib Vered | Chief Operating Officer | S 公開市場賣出 | 14.9K | 4.19 | 63K | 1.1M | SEC |
| 2022-11-21 | 11-22 | Bisker-Leib Vered | Chief Operating Officer | S 公開市場賣出 | 16.0K | 4.34 | 70K | 1.1M | SEC |
| 2022-11-18 | 11-22 | Bisker-Leib Vered | Chief Operating Officer | S 公開市場賣出 | 6.2K | 4.40 | 27K | 1.1M | SEC |
| 2022-11-08 | 11-10 | GORDON CARL L | Director,TenPercentOwner | P 公開市場買進 | 402K | 3.21 | 1.3M | 15.2M | SEC |
| 2022-11-08 | 11-10 | ORBIMED ADVISORS LLC | Director,TenPercentOwner | P 公開市場買進 | 402K | 3.21 | 1.3M | 15.2M | SEC |
| 2022-11-08 | 11-10 | OrbiMed Capital GP V LLC | Director,TenPercentOwner | P 公開市場買進 | 402K | 3.21 | 1.3M | 15.2M | SEC |
| 2022-11-08 | 11-10 | OrbiMed Genesis GP LLC | Director,TenPercentOwner | P 公開市場買進 | 402K | 3.21 | 1.3M | 15.2M | SEC |
| 2022-09-28 | 09-28 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | P 公開市場買進 | 10.0K | 2.32 | 23K | 5.4M | SEC |
| 2022-09-26 | 09-27 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | P 公開市場買進 | 15.0K | 2.27 | 34K | 5.4M | SEC |
| 2022-09-07 | 09-08 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | P 公開市場買進 | 15.0K | 3.03 | 45K | 5.4M | SEC |
| 2022-09-01 | 09-01 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | P 公開市場買進 | 15.0K | 2.83 | 42K | 5.4M | SEC |
| 2022-08-17 | 08-17 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | P 公開市場買進 | 15.0K | 3.05 | 46K | 5.4M | SEC |
| 2022-08-10 | 08-10 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | P 公開市場買進 | 15.0K | 2.64 | 40K | 5.4M | SEC |
| 2022-08-01 | 08-02 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | P 公開市場買進 | 15.0K | 2.58 | 39K | 5.3M | SEC |
| 2022-06-21 | 06-21 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | P 公開市場買進 | 20.0K | 2.80 | 56K | 5.3M | SEC |
| 2022-06-16 | 06-17 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | P 公開市場買進 | 20.0K | 2.34 | 47K | 5.3M | SEC |
| 2022-06-13 | 06-13 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | P 公開市場買進 | 30.0K | 2.29 | 69K | 5.3M | SEC |
| 2022-06-06 | 06-07 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | P 公開市場買進 | 30.0K | 2.83 | 85K | 5.3M | SEC |
| 2022-06-01 | 06-01 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | P 公開市場買進 | 20.0K | 3.03 | 61K | 5.2M | SEC |
| 2022-05-26 | 05-26 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | P 公開市場買進 | 20.0K | 3.04 | 61K | 5.2M | SEC |
| 2022-05-23 | 05-24 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | P 公開市場買進 | 18.4K | 2.72 | 50K | 5.2M | SEC |
| 2022-05-17 | 05-17 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | P 公開市場買進 | 20.2K | 2.47 | 50K | 5.2M | SEC |
| 2022-05-13 | 05-13 | GORDON CARL L | Director,TenPercentOwner | P 公開市場買進 | 30.7K | 2.49 | 76K | 14.8M | SEC |
| 2022-05-13 | 05-13 | OrbiMed Capital GP V LLC | Director,TenPercentOwner | P 公開市場買進 | 30.7K | 2.49 | 76K | 14.8M | SEC |
| 2022-05-13 | 05-13 | ORBIMED ADVISORS LLC | Director,TenPercentOwner | P 公開市場買進 | 30.7K | 2.49 | 76K | 14.8M | SEC |
| 2022-05-13 | 05-13 | OrbiMed Genesis GP LLC | Director,TenPercentOwner | P 公開市場買進 | 30.7K | 2.49 | 76K | 14.8M | SEC |
| 2022-05-12 | 05-13 | OrbiMed Genesis GP LLC | Director,TenPercentOwner | P 公開市場買進 | 97.1K | 2.35 | 228K | 14.8M | SEC |
| 2022-05-12 | 05-13 | ORBIMED ADVISORS LLC | Director,TenPercentOwner | P 公開市場買進 | 97.1K | 2.35 | 228K | 14.8M | SEC |
| 2022-05-12 | 05-13 | OrbiMed Capital GP V LLC | Director,TenPercentOwner | P 公開市場買進 | 97.1K | 2.35 | 228K | 14.8M | SEC |
| 2022-05-12 | 05-13 | GORDON CARL L | Director,TenPercentOwner | P 公開市場買進 | 97.1K | 2.35 | 228K | 14.8M | SEC |
| 2022-05-11 | 05-13 | OrbiMed Capital GP V LLC | Director,TenPercentOwner | P 公開市場買進 | 64.7K | 1.79 | 116K | 14.7M | SEC |
| 2022-05-11 | 05-13 | GORDON CARL L | Director,TenPercentOwner | P 公開市場買進 | 64.7K | 1.79 | 116K | 14.7M | SEC |
| 2022-05-11 | 05-13 | ORBIMED ADVISORS LLC | Director,TenPercentOwner | P 公開市場買進 | 64.7K | 1.79 | 116K | 14.7M | SEC |
| 2022-05-11 | 05-13 | OrbiMed Genesis GP LLC | Director,TenPercentOwner | P 公開市場買進 | 64.7K | 1.79 | 116K | 14.7M | SEC |
| 2022-05-10 | 05-10 | ORBIMED ADVISORS LLC | Director,TenPercentOwner | P 公開市場買進 | 24.4K | 1.60 | 39K | 14.6M | SEC |
| 2022-05-10 | 05-10 | OrbiMed Genesis GP LLC | Director,TenPercentOwner | P 公開市場買進 | 24.4K | 1.60 | 39K | 14.6M | SEC |
| 2022-05-10 | 05-10 | OrbiMed Capital GP V LLC | Director,TenPercentOwner | P 公開市場買進 | 24.4K | 1.60 | 39K | 14.6M | SEC |
| 2022-05-10 | 05-10 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | P 公開市場買進 | 27.8K | 1.80 | 50K | 5.2M | SEC |
| 2022-05-10 | 05-10 | GORDON CARL L | Director,TenPercentOwner | P 公開市場買進 | 24.4K | 1.60 | 39K | 14.6M | SEC |
| 2022-05-09 | 05-10 | OrbiMed Capital GP V LLC | Director,TenPercentOwner | P 公開市場買進 | 90.7K | 1.56 | 142K | 14.6M | SEC |
| 2022-05-09 | 05-10 | GORDON CARL L | Director,TenPercentOwner | P 公開市場買進 | 90.7K | 1.56 | 142K | 14.6M | SEC |
| 2022-05-09 | 05-10 | ORBIMED ADVISORS LLC | Director,TenPercentOwner | P 公開市場買進 | 90.7K | 1.56 | 142K | 14.6M | SEC |
| 2022-05-09 | 05-10 | OrbiMed Genesis GP LLC | Director,TenPercentOwner | P 公開市場買進 | 90.7K | 1.56 | 142K | 14.6M | SEC |
| 2022-05-06 | 05-10 | OrbiMed Capital GP V LLC | Director,TenPercentOwner | P 公開市場買進 | 10.2K | 1.63 | 17K | 14.5M | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 18.0M | 39.4M | 新進 | 新進 |
| ORBIMED ADVISORS LLC | 15.2M | 33.3M | 新進 | 新進 |
| MONTANOVA CAPITAL, LLC | 14.1M | 30.9M | 新進 | 新進 |
| BlackRock, Inc. | 11.3M | 24.7M | 新進 | 新進 |
| STATE STREET CORP | 10.0M | 21.8M | 新進 | 新進 |
| ENAVATE SCIENCES GP, LLC | 7.8M | 17.1M | 新進 | 新進 |
| Vivo Capital, LLC | 7.8M | 17.0M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.1M | 13.4M | 新進 | 新進 |
| Palo Alto Investors LP | 5.8M | 12.8M | 新進 | 新進 |
| 千禧 MILLENNIUM MANAGEMENT LLC | 4.7M | 10.3M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 3.8M | 8.4M | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.8M | 8.3M | 新進 | 新進 |
| Qube Research & Technologies Ltd | 3.7M | 8.1M | 新進 | 新進 |
| Blue Owl Capital Holdings LP | 3.6M | 7.9M | 新進 | 新進 |
| 城堡 CITADEL ADVISORS LLC | 3.6M | 7.8M | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 3.5M | 7.7M | 新進 | 新進 |
| Rock Springs Capital Management LP | 3.5M | 7.7M | 新進 | 新進 |
| AQR CAPITAL MANAGEMENT LLC | 3.5M | 7.7M | 新進 | 新進 |
| Birchview Capital, LP | 1.7M | 3.7M | 新進 | 新進 |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1.4M | 3.1M | 新進 | 新進 |
| Fisher Asset Management, LLC | 1.4M | 3.0M | 新進 | 新進 |
| ROYCE & ASSOCIATES LP | 1.3M | 2.9M | 新進 | 新進 |
| FMR LLC | 1.2M | 2.7M | 新進 | 新進 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.2M | 2.6M | 新進 | 新進 |
| NORTHERN TRUST CORP | 1.1M | 2.5M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 216 +15 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 216 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 166M · 92.0% |
| 合計季末市值 | 360M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 40.8M |
|---|---|
| 與上期比 | +1.5% |
| 佔流通股數 | 22.65% |
| 日均成交量 | 2.4M |
| 回補天數 | 17.3 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 40.8M | +1.5% | 22.65% | 2.4M | 17.3 |
| 2026-08-14 | 40.2M | +0.8% | 22.32% | 4.1M | 9.8 |
| 2026-07-31 | 39.9M | +1.5% | 22.14% | 2.3M | 17.6 |
| 2026-07-15 | 39.3M | +5.8% | 21.82% | 2.5M | 15.7 |
| 2026-06-30 | 37.1M | +14.3% | 20.62% | 4.2M | 8.9 |
| 2026-06-15 | 32.5M | -2.3% | 18.05% | 3.4M | 9.5 |
| 2026-05-29 | 33.3M | +7.3% | 18.47% | 5.2M | 6.4 |
| 2026-05-15 | 31.0M | +2.0% | 17.23% | 7.6M | 4.1 |
| 2026-04-30 | 30.4M | +16.7% | 16.89% | 22.6M | 1.4 |
| 2026-04-15 | 26.1M | -0.2% | 14.48% | 2.8M | 9.4 |
| 2026-03-31 | 26.1M | +9.7% | 14.51% | 2.2M | 12.1 |
| 2026-03-13 | 23.8M | +3.5% | 13.23% | 2.0M | 11.8 |
| 2026-02-27 | 23.0M | +2.9% | 12.78% | 1.9M | 12.3 |
| 2026-02-13 | 22.4M | +2.0% | 12.42% | 2.0M | 11.3 |
| 2026-01-30 | 21.9M | -4.6% | 12.18% | 2.2M | 9.9 |
| 2026-01-15 | 23.0M | +6.5% | 12.77% | 2.9M | 7.8 |
| 2025-12-31 | 21.6M | +16.6% | 11.99% | 2.0M | 10.7 |
| 2025-12-15 | 18.5M | +6.3% | 10.28% | 1.7M | 11.1 |
| 2025-11-28 | 17.4M | +4.9% | 9.67% | 2.1M | 8.3 |
| 2025-11-14 | 16.6M | -0.5% | 9.22% | 2.1M | 7.7 |
| 2025-10-31 | 16.7M | +8.7% | 9.27% | 1.8M | 9.3 |
| 2025-10-15 | 15.4M | +3.7% | 8.53% | 1.8M | 8.7 |
| 2025-09-30 | 14.8M | +22.0% | 8.23% | 1.8M | 8.1 |
| 2025-09-15 | 12.1M | +18.4% | 6.74% | 917K | 13.2 |
| 2025-08-29 | 10.3M | +7.6% | 5.69% | 1.0M | 10.0 |
| 2025-08-15 | 9.5M | +17.5% | 5.29% | 1.8M | 5.4 |